Mai Huang, M.D., Executive Director, Drug Safety and Pharmacovigilance at Avanir shared her thoughts about the importance of pharmacovigilance for drug safety. “At Avanir Pharmaceuticals, safety is our number one priority. We are committed to delivering innovative central nervous system (CNS) solutions that help improve the lives of patients and their care communities. To achieve our mission, it’s vital to maintain a diligent, robust and resourceful pharmacovigilance system.”
Read more here.